CSB Genomics Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $77.5K

  • Investors
  • 1

CSB Genomics General Information


Developer of treatment for non-invasive cancer designed to provide personalized anticancer drug therapy for non-invasive cancer diseases.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Moscow
  • Russia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CSB Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 30-Sep-2016 $77.5K 000.00 Completed Generating Revenue
1. Merger/Acquisition 01-Oct-2015 Completed Generating Revenue
To view CSB Genomics’s complete valuation and funding history, request access »

CSB Genomics Executive Team (1)

Name Title Board Seat Contact Info
Vladislav Mileiko Chief Executive Officer
To view CSB Genomics’s complete executive team members history, request access »